| Year |
Citation |
Score |
| 2023 |
Littlepage-Saunders M, Hochstein MJ, Chang DS, Johnson KA. G protein-coupled receptor modulation of striatal dopamine transmission: Implications for psychoactive drug effects. British Journal of Pharmacology. PMID 37258878 DOI: 10.1111/bph.16151 |
0.348 |
|
| 2022 |
Lovinger DM, Mateo Y, Johnson KA, Engi SA, Antonazzo M, Cheer JF. Local modulation by presynaptic receptors controls neuronal communication and behaviour. Nature Reviews. Neuroscience. 23: 191-203. PMID 35228740 DOI: 10.1038/s41583-022-00561-0 |
0.553 |
|
| 2022 |
Ferranti AS, Johnson KA, Winder DG, Conn PJ, Joffe ME. Prefrontal cortex parvalbumin interneurons exhibit decreased excitability and potentiated synaptic strength after ethanol reward learning. Alcohol (Fayetteville, N.Y.). PMID 35227826 DOI: 10.1016/j.alcohol.2022.02.003 |
0.55 |
|
| 2020 |
Johnson KA, Lovinger DM. Reinforcing actions through the thalamostriatal circuit. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32814831 DOI: 10.1038/s41386-020-00814-5 |
0.436 |
|
| 2020 |
Johnson KA, Lovinger DM. Allosteric modulation of metabotropic glutamate receptors in alcohol use disorder: Insights from preclinical investigations. Advances in Pharmacology (San Diego, Calif.). 88: 193-232. PMID 32416868 DOI: 10.1016/bs.apha.2020.02.002 |
0.511 |
|
| 2020 |
Johnson KA, Voyvodic L, Loewinger GC, Mateo Y, Lovinger DM. Operant self-stimulation of thalamic terminals in the dorsomedial striatum is constrained by metabotropic glutamate receptor 2. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31995814 DOI: 10.1038/S41386-020-0626-Y |
0.613 |
|
| 2019 |
Johnson KA, Liput DJ, Homanics GE, Lovinger DM. Age-dependent impairment of metabotropic glutamate receptor 2-dependent long-term depression in the mouse striatum by chronic ethanol exposure. Alcohol (Fayetteville, N.Y.). PMID 31233806 DOI: 10.1016/J.Alcohol.2019.06.003 |
0.576 |
|
| 2018 |
Kupferschmidt DA, Augustin SM, Johnson KA, Lovinger DM. Active zone proteins RIM1αβ are required for normal corticostriatal transmission and action control. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30559150 DOI: 10.1523/Jneurosci.1940-18.2018 |
0.722 |
|
| 2017 |
Mateo Y, Johnson KA, Covey DP, Atwood BK, Wang HL, Zhang S, Gildish I, Cachope R, Bellocchio L, Guzmán M, Morales M, Cheer JF, Lovinger DM. Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens. Neuron. 96: 1112-1126.e5. PMID 29216450 DOI: 10.1016/J.Neuron.2017.11.012 |
0.698 |
|
| 2017 |
Kupferschmidt DA, Juczewski K, Cui G, Johnson KA, Lovinger DM. Parallel, but Dissociable, Processing in Discrete Corticostriatal Inputs Encodes Skill Learning. Neuron. 96: 476-489.e5. PMID 29024667 DOI: 10.1016/J.Neuron.2017.09.040 |
0.649 |
|
| 2017 |
Johnson KA, Mateo Y, Lovinger DM. Metabotropic glutamate receptor 2 inhibits thalamically-driven glutamate and dopamine release in the dorsal striatum. Neuropharmacology. PMID 28159646 DOI: 10.1016/J.Neuropharm.2017.01.038 |
0.649 |
|
| 2016 |
Johnson KA, Lovinger DM. Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction? Frontiers in Cellular Neuroscience. 10: 264. PMID 27891077 DOI: 10.3389/Fncel.2016.00264 |
0.56 |
|
| 2016 |
Johnson KA, Lovinger DM. Presynaptic Plasticity Found in Translation. Neuron. 92: 269-272. PMID 27764658 DOI: 10.1016/J.Neuron.2016.09.047 |
0.54 |
|
| 2015 |
Johnson KA, Lovinger DM. Metabotropic Glutamate Receptor 2 Positive Allosteric Modulators: Closing the Gate on Drug Abuse? Biological Psychiatry. 78: 436-8. PMID 26360546 DOI: 10.1016/J.Biopsych.2015.07.008 |
0.548 |
|
| 2015 |
Rook JM, Xiang Z, Lv X, Ghoshal A, Dickerson JW, Bridges TM, Johnson KA, Foster DJ, Gregory KJ, Vinson PN, Thompson AD, Byun N, Collier RL, Bubser M, Nedelcovych MT, et al. Biased mGlu5-Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu5 Modulation of NMDAR Currents. Neuron. 86: 1029-40. PMID 25937172 DOI: 10.1016/J.Neuron.2015.03.063 |
0.411 |
|
| 2014 |
Yin S, Noetzel MJ, Johnson KA, Zamorano R, Jalan-Sakrikar N, Gregory KJ, Conn PJ, Niswender CM. Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 79-94. PMID 24381270 DOI: 10.1523/Jneurosci.1129-13.2014 |
0.397 |
|
| 2013 |
Johnson KA, Jones CK, Tantawy MN, Bubser M, Marvanova M, Ansari MS, Baldwin RM, Conn PJ, Niswender CM. The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease. Neuropharmacology. 66: 187-95. PMID 22546615 DOI: 10.1016/J.Neuropharm.2012.03.029 |
0.413 |
|
| 2011 |
Johnson KA, Niswender CM, Conn PJ, Xiang Z. Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulata. Neuroscience Letters. 504: 102-6. PMID 21945652 DOI: 10.1016/J.Neulet.2011.09.007 |
0.426 |
|
| 2010 |
Niswender CM, Johnson KA, Miller NR, Ayala JE, Luo Q, Williams R, Saleh S, Orton D, Weaver CD, Conn PJ. Context-dependent pharmacology exhibited by negative allosteric modulators of metabotropic glutamate receptor 7. Molecular Pharmacology. 77: 459-68. PMID 20026717 DOI: 10.1124/Mol.109.058768 |
0.401 |
|
| 2009 |
Johnson KA, Conn PJ, Niswender CM. Glutamate receptors as therapeutic targets for Parkinson's disease. Cns & Neurological Disorders Drug Targets. 8: 475-91. PMID 19702565 DOI: 10.2174/187152709789824606 |
0.394 |
|
| 2009 |
Williams R, Johnson KA, Gentry PR, Niswender CM, Weaver CD, Conn PJ, Lindsley CW, Hopkins CR. Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4). Bioorganic & Medicinal Chemistry Letters. 19: 4967-70. PMID 19640716 DOI: 10.1016/J.Bmcl.2009.07.072 |
0.312 |
|
| 2008 |
Niswender CM, Johnson KA, Weaver CD, Jones CK, Xiang Z, Luo Q, Rodriguez AL, Marlo JE, de Paulis T, Thompson AD, Days EL, Nalywajko T, Austin CA, Williams MB, Ayala JE, et al. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4. Molecular Pharmacology. 74: 1345-58. PMID 18664603 DOI: 10.1124/Mol.108.049551 |
0.379 |
|
| 2008 |
Niswender CM, Johnson KA, Luo Q, Ayala JE, Kim C, Conn PJ, Weaver CD. A novel assay of Gi/o-linked G protein-coupled receptor coupling to potassium channels provides new insights into the pharmacology of the group III metabotropic glutamate receptors. Molecular Pharmacology. 73: 1213-24. PMID 18171729 DOI: 10.1124/Mol.107.041053 |
0.353 |
|
| 2008 |
Shirey JK, Xiang Z, Orton D, Brady AE, Johnson KA, Williams R, Ayala JE, Rodriguez AL, Wess J, Weaver D, Niswender CM, Conn PJ. An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission. Nature Chemical Biology. 4: 42-50. PMID 18059262 DOI: 10.1038/Nchembio.2007.55 |
0.367 |
|
| Show low-probability matches. |